

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and...
Puedes comprar acciones de AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID:ATXI) a través de cualquier corretaje en línea.
No hay competidores como tal para AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. tiene un precio objetivo de consenso de $56.25.
El precio de las acciones de AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID: ATXI) es de 0.385 dólares, actualizado por última vez el 23 de octubre de 2026 a las 9:30 GMT-4.
No hay dividendos previstos para AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
No hay informes de resultados previstos para AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
No hay ninguna división de acciones prevista para AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. está en el sector Health Care y en la industria Pharmaceuticals. Cotiza en el OTCID.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It is focused on advancing impactful therapies with the potential to...